Список проголосовавших за комментарий " On The Wires<ul><li>Ocular TherapeutiX (<strong>OCUL</strong>) announced new data to be presented from its most recent Phase 3 study evaluating the efficacy and safety of Dextenza for intracanalicular use, for the treatment of ocular pain and inflammation following cataract surgery, at the upcoming American Society of Cataract and Refractive Surgery Annual Meeting, being held May 5-9.</li><li>Inovio Pharmaceuticals (<strong>INO</strong>) has commenced a phase 2 trial to evaluate the efficacy of VGX-3100 in patients with pre-cancerous lesions of the vulva, or vulvar intraepithelial neoplasia. The immunotherapy will be administered with Inovio's Cellectra device. The primary endpoint of the study is histologic clearance of high-grade lesions and virologic clearance of the HPV virus in vulvar tissue samples. The study will also evaluate safety and tolerability of VGX-3100.</li><li>Lipocine (<strong>LPCN</strong>) announced the completion of enrollment for both its dosing validation study and its dosing flexibility study for LPCN 1021. Co anticipates announcing the top-line results from these studies in June 2017.</li><li>Torchlight Energy Resources (<strong>TRCH</strong>) has successfully tested the Flying B Ranch #2 vertical well in the Lower Wolfcamp A and Upper Wolfcamp B sections. The well is still in the flowback process and improving during clean-up of the 2000 barrels of frac load remaining. The well is currently testing at ~20 barrels of oil per day with associated gas which has yet to be measured.<ul><li>The Flying B Ranch #3H is being permitted and will be spud sometime in mid to late June.</li></ul></li><li>Micron Technology (<strong>MU</strong>) and Microsoft (<strong>MSFT</strong>) announced a collaboration that aims to address the major challenge of providing trusted computing models for IoT deployments in industrial, automotive and consumer environments.</li><li>RadNet (<strong>RDNT</strong>) announced that Shin Imaging Center has selected its Radiology Information System, PACS, Speech Recognition, and Patient and Physician Portals to manage its clinical and business workflows.</li></ul>"